Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and...
Mar 12, 2026, 4:27 PM EDT - 5 days ago
Jan 9, 2026, 8:00 AM EST - 2 months ago
Jan 7, 2026, 8:45 AM EST - 2 months ago
Dec 9, 2025, 8:00 AM EST - 3 months ago
Nov 14, 2025, 9:26 AM EST - 4 months ago
Nov 7, 2025, 1:56 PM EST - 4 months ago
Nov 6, 2025, 4:00 PM EST - 4 months ago
Oct 30, 2025, 4:00 PM EDT - 4 months ago
Oct 3, 2025, 4:00 PM EDT - 5 months ago
Sep 12, 2025, 9:45 AM EDT - 6 months ago
Sep 11, 2025, 5:20 AM EDT - 6 months ago
Sep 2, 2025, 10:43 AM EDT - 7 months ago
Aug 5, 2025, 11:25 AM EDT - 8 months ago
Aug 5, 2025, 8:00 AM EDT - 8 months ago
Jul 29, 2025, 8:30 AM EDT - 8 months ago
Jul 2, 2025, 8:32 AM EDT - 9 months ago
May 6, 2025, 2:40 PM EDT - 11 months ago
May 6, 2025, 8:00 AM EDT - 11 months ago
Apr 29, 2025, 8:00 AM EDT - 11 months ago
Apr 2, 2025, 4:05 PM EDT - 1 year ago
Mar 31, 2025, 9:59 AM EDT - 1 year ago
Mar 31, 2025, 8:00 AM EDT - 1 year ago
Mar 28, 2025, 4:07 PM EDT - 1 year ago
Dec 10, 2024, 8:00 AM EST - 1 year ago
Nov 14, 2024, 11:02 AM EST - 1 year ago
Nov 14, 2024, 8:00 AM EST - 1 year ago
Nov 7, 2024, 8:00 AM EST - 1 year ago
Oct 29, 2024, 6:04 AM EDT - 1 year ago
Sep 23, 2024, 8:30 AM EDT - 1 year ago
Sep 17, 2024, 7:30 AM EDT - 1 year ago
Aug 1, 2024, 3:44 PM EDT - 1 year ago
Aug 1, 2024, 8:00 AM EDT - 1 year ago
Jul 25, 2024, 8:00 AM EDT - 1 year ago
Jul 10, 2024, 7:30 AM EDT - 1 year ago
May 10, 2024, 8:00 AM EDT - 2 years ago
May 7, 2024, 8:08 PM EDT - 2 years ago
May 7, 2024, 8:00 AM EDT - 2 years ago
Apr 30, 2024, 8:00 AM EDT - 2 years ago
Apr 4, 2024, 7:30 AM EDT - 2 years ago
Feb 8, 2024, 2:04 PM EST - 2 years ago
Feb 8, 2024, 8:00 AM EST - 2 years ago
Feb 1, 2024, 8:00 AM EST - 2 years ago
Dec 12, 2023, 8:00 AM EST - 2 years ago
Dec 11, 2023, 8:00 AM EST - 2 years ago
Dec 6, 2023, 8:00 AM EST - 2 years ago
Dec 5, 2023, 8:00 AM EST - 2 years ago
Nov 17, 2023, 9:04 AM EST - 2 years ago
Nov 2, 2023, 2:32 PM EDT - 2 years ago
Nov 2, 2023, 8:00 AM EDT - 2 years ago